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Abstract
Cigarette smoking is an important risk factor for atherosclerosis, a chronic inflammatory disease. However the underlying
factors of this effect are unclear. It has been hypothesized that water-soluble components of cigarette smoke can directly
promote oxidative stress in vasculature and blood cells. Aim of this study was to study the relationship between oxidative
stress and inflammation in a group of young smokers. To do this we evaluated: 1) the oxidation products of phospholipids
(oxPAPC) in peripheral blood mononuclear cells (PBMC); 2) their role in causing PBMC reactive oxygen species (ROS)
generation and changes in GSH; 3) the expression of the transcription factor NF-E2-related factor 2 (Nrf2) and of related
antioxidant genes (ARE); 4) the activation of NF-kB and C-reactive protein (CRP) values. We studied 90 healthy volunteers: 32
non-smokers, 32 moderate smokers (5–10 cigarettes/day) and 26 heavy smokers (25–40 cigarettes/day). OxPAPC and
p47phox expression, that reasonably reflects NADPH oxidase activity, were higher in moderate smokers and heavy smokers
than in non-smokers (p,0.01), the highest values being in heavy smokers (p,0.01). In in vitro studies oxPAPC increased ROS
generation via NADPH oxidase activation. GSH in PBMC and plasma was lower in moderate smokers and heavy smokers
than in non-smokers (p,0.01), the lowest values being in heavy smokers (p,0.01). Nrf2 expression in PBMC was higher in
moderate smokers than in non-smokers (p,0.01), but not in heavy smokers, who had the highest levels of NF-kB and CRP
(p,0.01). In in vitro studies oxPAPC dose-dependently increased NF-kB activation, whereas at the highest concentrations
Nrf2 expression was repressed. The small interference (si) RNA-mediated knockdown of NF-kB/p65 increased about three
times the expression of Nrf2 stimulated with oxPAPC. Cigarette smoke promotes oxPAPC formation and oxidative stress in
PBMC. This may cause the activation of NF-kB that in turn may participate in the negative regulation of Nrf2/ARE pathway
favouring inflammation.
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Introduction
Atherosclerosis is a chronic inflammatory disease of the arterial
wall [1–3] with enormous epidemiological relevance [4,5]. Sound
evidence has been generated that oxidative stress is one of the most
potent inductor of vascular inflammation in atherogenesis [6].
Reactive oxygen species (ROS) are known to change the
oxidation-reduction (redox) state of the exposed cells and it is
known that several inflammatory genes and the related transcrip-
tion factors are regulated through redox-sensitive mechanisms [1].
Nuclear factor (NF)-kB was the first eukaryotic transcription factor
shown to respond directly to oxidative stress. A huge amount of
experimental data supports the activation of the transcription
factor NF-kB as a key redox-sensitive event associated with
vascular dysfunction (reviewed in 7). NF-kB intervenes in the
transcription of a large number of inflammatory genes coding for
cytokines, chemokines, and adhesion molecules [8].
Cigarette smoking is the worldwide leading cause of preventable
morbidity and mortality and constitutes a major risk factor for
atherosclerotic vascular disease, including stroke and coronary
artery disease [9]. Cigarette smoke can be divided into two phases:
tar and gas-phase smoke. Both phases contain high concentrations
of ROS, nitric oxide, peroxynitrite, and free radicals of organic
compounds [10,11]. In addition to these short-lived, highly
reactive substances, previous studies have shown that aqueous
cigarette tar extracts also contain pro-oxidant substances that have
the potential to increase cellular production of ROS [12]. Thus it
has been hypothesized that water-soluble components of cigarette
smoke that are likely to reach the systemic circulation can directly
promote oxidative stress in vasculature and blood cells [10,12].
The phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phos-
phorylcholine (PAPC) is a major component of cell membranes
and lipoproteins. Oxidation products of PAPC (oxPAPC) are
found in cells during inflammation, in membranes of apoptotic
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considered sensitive markers of oxidative stress (reviewed in 13).
Furthermore ox-PAPC have been shown to induce ROS
production in vascular cells that appears to be mediated largely
by NADPH-oxidase activity [14].
The antioxidant response element (ARE), also referred to as the
electrophile response element, is a cis-acting transcriptional
regulatory element involved in the activation of genes coding for
a number of antioxidant proteins and phase II detoxifying
enzymes including NADPH quinone oxidoreductase, glutathione
peroxidase, ferritin, gamma-glutamylcysteine synthetase (gGCS )
and heme oxygenase-1 (HO-1) [15]. NF-E2-related factor 2 (Nrf2)
is the transcription factor that is responsible for both constitutive
and inducible expression of the ARE-regulated genes [15]. Nrf2-
null mice have decreased basal and inducible expression of
antioxidant genes, increased oxidative stress, and decreased
reducing activity and antioxidant capacity [16], suggesting that
the Nrf2/ARE pathway is critical for the regulation of intracellular
redox status. Recently it has been shown that NF-kB p65 may
participate in the negative regulation of Nrf2/ARE signalling [17].
Since cigarette smoking is a risk factor for atherosclerosis that
promotes oxidative stress and oxidative stress has been shown to
induce the redox sensitive transcription factor NF-kB, as well as
the counteracting Nrf2/ARE pathway, we aimed this study to
evaluate the balance between these two inducible processes in
blood cells derived from young healthy smokers and the effects on
systemic indices of inflammation.
Methods
Participants
The study was approved by the Ethical Committee of
University of Verona and all participants provided written consent
prior to commencing the study.
Healthy volunteers were recruited among the students of
Verona University and among nurses of local Universitary
Hospital. A group of heavy smokers was also recruited from the
regional center for smoking. The healthy volunteers were recruited
according to the following criteria: male and female; aged 18–35
years; BMI 19–28 kg/m
2; drink less than 5 units of alcohol per
week, with 1 unit equivalent to 7.9 g alcohol; should not be
following a weight reducing diet, exercise no more than 3630 min
aerobic exercise per week; no use of antioxidant supplementation
or anti-inflammatory medication during or for six months prior to
commencing the study; no diagnosed heart disease, diabetes or
endocrine disorder. Smokers were described as individuals who
smoked 5–10 (moderate smokers) or 25–40 (heavy smokers)
cigarettes per day for at least 3 years, whilst non-smokers included
those who had never smoked or those who had not smoked for at
least 3 years.
Blood Samples and Peripheral Blood Mononuclear Cells
(PBMC) Isolation
Venous blood samples were obtained from volunteers after 12 h
fasting.
Blood was collected from each subject and drawn into pyrogen-
free blood collection tubes. Multiple aliquots of serum or plasma
were placed into sterile 1-ml screw-capped polypropylene vials,
containing phenolic antioxidant 2,6-Di-tert-butyl-4-methylphenol
(BHT) (10 mM) (SIGMA) to inhibit lipid peroxidation, and stored
at 280uC. Samples were kept frozen for no longer than 9 months
with an average of 5 months. The samples were frozen and thawed
only once. PBMC were isolated as previously described [18].
Briefly whole blood was layered onto a sterile aqueous medium
containing ficoll and sodium diatrizoate at a predetermined
density of 1.007 g/ml at 25uC. Gentle centrifugation at room
temperature resulted in the separation of PBMC at the blood/
ficoll interface, with the other white and red blood cells passing
through the interface. Total cholesterol, high density lipoprotein
(HDL) cholesterol, LDL cholesterol, triglycerides, glucose, white
blood cell (WBC) count, were measured with standard methods.
C-reactive protein (CRP) was measured by a commercially
available high sensitivity turbidimetric method (Syncron-PCR,
Beckman). Interleukin- (IL) 6 in plasma was measured with a
commercial assay kit (Quantikine, R&D System).
Evaluation of oxPAPC in PBMC and Plasma from Non-
Smokers, Moderate Smokers and Heavy Smokers
OxPAPC in PBMC and plasma of non-smokers and smokers
were measured on an Agilent mass spectrometer equipped with an
electrospray source as previously described [19]. The following
different oxPAPC were taken into consideration: 1-palmitoyl-2-
(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphocholine (PEIPC);
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine
(POVPC); 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
(PGPC). Flow injection experiments were performed by an HPLC
system (HP1100; Agilent Technologies). Quantification of the
peak areas was performed by single ion monitoring in the elution
time range of 10–20 min using appropriate software.
Authentic1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocho-
line (PAPC), POVPC and PGPC were obtained from Avanti Polar
Lipids, Inc. (Alabaster, AL). PEIPC was prepared and analyzed in
our laboratory as previously described [20].
Quantitative Real-Time PCR
Quantitative Real-Time PCR analysis was performed as previously
described [18]. Total RNA was extracted from PBMC of moderate
smokers, heavy smokers and non-smokers with a RNeasy Mini Kit
(Qiagen) and was reverse transcribed using IScriptcDNASynthesis Kit
(Bio-Rad, Hercules, CA). The relative expression levels of mRNA
encoding Nrf2, HO-1, IkB-alpha, gGCS, p47phox, p65, IL-6 and
beta-actin were measured by iCycler (Bio-Rad, Hercules, CA), using
IQSYBR Green PCR SuperMix (Bio-Rad, Hercules, CA) and
300 nM each primer pair. Primers were designed by Beacon Design
4.0 software (PREMIER Biosoft International, Palo Alto, CA, USA)
and synthesized by MWG Biotech AG (Ebersberg, Germany) (Nrf2,
sense 59-TTCAGCCAGCCCAGCACATC-39 and antisense 59-CG-
TAGCCGAAGAAACCTCATTGTC-39;H O - 1 ,s e n s e5 9-GGTGA-
CCCGAGACGGCTTC-39 and antisense 59-AGACTGGGC TCT-
CCTTGTTGC-39;I k B - a l p h a ,s e n s e5 9-CGCACCTCCACTCCA-
TCCTG-39,a n t i s e n s e5 9-GCATTGACATCAGCACCCAAGG-39;
gamma-glutamylcysteine synthetase (gGCS) (heavy chain), sense 59
CGAATTCGCCAAGAATGAGGAGATCC -39,a n t i s e n s e5 9-C G -
AATTCGAAAGCGACGGCTGTACC-39; p47phox, sense 59-CC-
CACAGACAACCAG ACAAA-39,a n t i s e n s e5 9-TTTGTCTGGTT-
GTCTGTGGG-3; p65, sense 59-GGCCATGGACGAACT GTT-
CCC-39, antisense GGAGGGTCCTTGGTGACCAG-39;I L - 6 ,
sense 59-GCGCCTTCGGTCCAGTTG-39,a n t i s e n s e5 9-CTGCTT-
TCTCAGGGCTGAG 39; b-actin, sense 5- ATCAAGATCATT-
GCTCCTCCTG-3 and antisense 59- GCAACTAAGTCATAGTC-
CGCC-39). Normalized gene expression levels were given as the ratio
between the mean value for the target gene and that for the beta-actin
in each sample.
Western Blot Analysis
Western blot analysis was performed as previously described
[18]. Nrf2, HO-1, gGCS, IkB-alpha, p47phox and p65 were
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nuclear lysate with mouse monoclonal anti-Nrf2 (437C2a), anti
HO-1 (HO-1-1), anti-gamma-GCS (LL-8), anti-IkB-alpha (H-4),
anti-p47phox (A-7), anti-p65 (340C1a), anti IL-6 (A00042.01)
antibodies, and anti-bet-actin (Santa Cruz Biotechnology). Im-
mune complexes were captured with protein A/G-Sepharose
beads (Pierce) for 2 h at 4uC, and the beads were washed four
times with 100 mM NaCl. To ensure the specificity of protein-
antibody interaction, lysates were incubated with beads in the
absence of antibody as well as with an irrelevant immunoglobulin
isotype control (Caltag). Nrf2, HO-1, gGCS, IkB-alpha, p47phox
and p65 were detected by probing immunoprecipitates with rabbit
polyclonal anti Nrf2 (C-20) (sc-722), anti HO-1 (H105) (sc-10789),
anti gGCS (H-300) (sc-22755), anti IkB-alpha (C-15) (sc-203), anti
p47phox (H-195) (sc-14015), anti p-65 (A) (sc-109), anti IL-6 (H-
183) (sc-7920) and beta-actin (N-21) (sc-130656) antibodies (Santa
Cruz Biotechnology), followed by goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody (Bio-Rad). Reactive
antigens were visualized with Supersignal chemiluminescence
substrate (Pierce) at about 110 (Nrf2), 32 (HO-1), 73 (gGCS), 37
(IkB-alpha), 47 (p47phox), 65 (p65), 26 (IL-6) and 43 (beta-actin)
kDa and quantified by densitometric analysis with ChemiDoc
XRS (Bio-Rad). Protein expression data was quantified with
Quantity One Software (Bio-Rad). As positive control tert-
butylhydroquinone (t-BHQ) (100 mM) (Sigma-Aldrich) and phor-
bol myristate acetate (PMA) (100 nM) (Sigma-Aldrich) were used
respectively for Nrf2, HO-1, gamma-GCS and for p47phox, IkB-
alpha, p65, NF-kB and IL-6.
Measurement of NF-kB Activation in Isolated PBMC
Nuclear factor-kB activation was measured by a sensitive multi-
well colorimetric assay for nuclear NF-kB (TRANS-AM; Active
Motif, Rixensart, Belgium), as previously described [21]. Nuclear
extract was obtained by utilizing the nuclear extract kit supplied by
Active Motif. As a reference, recombinant p65 (Active Motif) was
used.
GSH Measurement in PBMC and Plasma
The detailed procedures for the measurements of cellular and
plasma GSH have been previously described [22]. Samples were
collected directly into specially prepared tubes containing
preservative BHT (10 mM) to reduce auto-oxidation, and frozen
at 280uC. Samples were analyzed using high-performance liquid
chromatography with fluorescence detection of 7-fluorobenzo-2-
oxa-1,3-diazol-4-sulfonic acid (SBD-F) at excitation 385 nm and
emission 515 nm.
Effect of Purified oxPAPC on ROS Generation, on
Expression of Nrf2/ARE Pathway and on NF-kB Activation
in PBMC of Healthy Donors
Purified monocytes (3610
5/ml, 200 ml/well) of healthy donors
were cultured in RPMI 1640 containing L-glutamine (GIBCO) for
20 hours at 37uC with increasing amounts (from 8 to 32 mM) of
POVPC, PGPC and PEIPC.
Some experiments were performed in the presence of the
inhibitors of NADPH oxidase apocynin (50 mM) and diphenylio-
donium (DPI) (50 mM), vitamin C (0–400 mM) and after small
interference (si) RNA-mediated knockdown of p47phox, Nrf2 and
p65. ROS were measured as described [23]. Cell viability was
monitired by using 7-amino-actinomycin D (7-AAD)-(BD Biosci-
ences) [24]. Endotoxin contamination of cell cultures was routinely
excluded with the chromogenic Limulus amebocyte lysate assay
(Sigma).
siRNA-Mediated Knockdown of p47phox, Nrf2 and p65
Cells were transfected with siRNA against p47phox (59-
TTTGTCTGGTTGT TGTGGG-39), or scrambled (sc) siRNA
(Ambion, Austin, TX), against Nrf2 siRNA (59-GUUUUUC-
CAGCUCAUACUCUUTT-39), or negative control (Invitrogen)
and against p65 (59-GAUCAAUGGCUACACAGGA-39), or
negative control (GenPharma) as previously described [25].
Statistical Analysis
Data are expressed as means 6 SD values if normally
distributed. Normal distribution of the data was determined using
Shapiro-Wilk test. Differences between continuous data were
analysed by two-tailed unpaired Student’s t-test. Statistical
comparison between 3 groups was performed by one-way
ANOVA and post-hoc multiple comparison using Student-New-
mann-Keuls’ test. Relationship between variables was assessed by
linear regression. A probability value (p),0.05 was considered to
Table 1. Clinical and metabolic characteristics of non-smokers, moderate smokers and heavy smokers.
NON-SMOKERS (n=32) MODERATE SMOKERS (n=32) HEAVY SMOKERS (n=26) P
Age 25.363.4 26.763.9 30.363.6 ns
Male/female 16/16 18/14 12/14 ns
BMI (Kg/m2) 22.662.6 23.763.7 22.863.1 ns
SBP (mmHg) 111.7612.6 113.269.1 114.368.5 ns
DBP (mmHg) 73.9612.2 74.668.6 75.368.2 ns
Heart rate (bpm) 66.669.6 69.768.0 71.367.8 ns
Waist circumference (cm) 78.0610.8 76.3611.4 76.8610.4 ns
Total cholesterol (mg/dl) 190.7629.6 184.8634.7 188.4622.3 ns
LDL cholesterol (mg/dl) 109.5626.1 106.8626.9 104.3619.7 ns
HDL cholesterol (mg/dl) 53.5610.2 57.4,611.2 54.4610.9 ns
Triglycerides (mg/dl) 84.5638,5 87.2647,6 94.3634.3 ns
Plasma glucose (mg/dl) 72.7610.4 73.167.5 75.368.2 ns
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure.
doi:10.1371/journal.pone.0008225.t001
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for Macintosh (SPSS, Chicago, III.).
Results
Clinical Characteristics of the Subjects
Along a period of 6 months, 124 healthy volunteers were invited
to participate to the study; of these only 90 (32 non-smokers, 32
moderate smokers and 26 heavy smokers) fully satisfied the
enrolling criteria. Clinical and metabolic characteristics of the
subjects are described in Table 1. There were no statistical
differences among the clinical and metabolic data in non-smokers,
moderate smokers and heavy smokers.
Inflammatory Markers and GSH Concentrations
Moderate smokers and heavy smokers had significantly higher
number of WBC, neutrophils, levels of circulating IL-6 and CRP
(p,0.01) and lower GSH concentrations (both in PBMC and
plasma) than non-smokers (p,0.01) (Table 2). These inflamma-
tory markers resulted significantly higher and cellular and plasma
GSH levels significantly lower in heavy smokers than in moderate
smokers (p,0.01).
OxPAPC Concentrations in PBMC and Plasma of Non-
Smokers, Moderate Smokers and Heavy Smokers
Figure 1 shows the mean concentrations of PEIPC, POVPC
and PGPC in PBMC derived from non-smokers, moderate
smokers and heavy smokers. PEIPC, POVPC and PGPC resulted
significantly higher in PBMC of moderate smokers and heavy
smokers than in non-smokers (p,0.01). PEIPC, POVPC and
PGPC were higher in heavy smokers than in moderate smokers
(p,0.01).
Expression of IkB-Alpha, p47phox, p65, Nrf2, HO-1, gGCS,
Activation of NF-kB and Expression of IL-6 in PBMC of
Non-Smokers, Moderate Smokers and Heavy Smokers
Figure 2 and 3 show the mRNA and protein expression of IkB-
alpha, p47phox, p65, Nrf2, HO-1 and gGCS in PBMC derived
from non-smokers, moderate smokers and heavy smokers. As
previously demonstrated, figure 3 B also shows that Nrf2 migrated
at 110 kDa in spite of its lower molecular weight [26]. PBMC
expression of IkB-alpha, p47phox, p65 and of Nrf2, HO-1 and
gGCS was significantly higher in moderate smokers than in non-
smokers (p,0.01). In heavy smokers only IkB-alpha, p47phox and
p65 expression was higher than in moderate smokers (p,0.01),
while Nrf2, HO-1 and gGCS expression was similar to non-
smokers (p,0.01).
Figures 4 and 5 show the concentrations of nuclear NF-kB
and the expression of IL-6 in PBMC of non-smokers, moderate
smokers and heavy smokers. Nuclear NF-kB concentrations
and IL-6 expression were higher in moderate smokers and
heavy smokers than in non-smokers (p,0.01). NF-kB values
and IL-6 expression resulted significantly higher in heavy
s m o k e r st h a ni nm o d e r a t es m o k e r s( p ,0.01). In moderate and
heavy smokers a negative correlation was found between Nrf2
protein expression and the concentration of nuclear NF-kB
using recombinant p65 as a reference (r=20.71, p,0.001)
(Figure 6).
Figure 1. Concentrations of oxidized phospholipids in periph-
eral blood mononuclear cells (PBMC). Results are the means6SD
of measurements performed in triplicate and are expressed in ng/mg
PAPC. *p,0.01 versus non-smokers; {p,0.01 versus moderate smokers.
PAPC=1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine;
PEIPC=1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phospho-
choline; POVPC=1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phospho-
rylcholine; PGPC=1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcho-
line.
doi:10.1371/journal.pone.0008225.g001
Table 2. Inflammatory markers and GSH concentrations in non-smokers, moderate smokers and heavy smokers.
NON-SMOKERS (n=32) MODERATE SMOKERS (n=32) HEAVY SMOKERS (n=26) P
WBC (mmc) 5279.66965.3 6576.861670.4* 7800.86881*{ ,0.01
Neutrophils (mmc) 2825.36751.7 3713.761441.6* 4821.86754*{ ,0.01
Lymphocytes (mmc) 1856.66365.3 2186.46656.5 2024.56411 ns
Monocytes (mmc) 371.76171.0 436.96168.5 411.76181 ns
IL-6 (pg/ml) 0.3260.041 0.6860.066 1.5460,21 ,0.01
CRP (mg/dl) 0.0660.007 0.13+0.015* 0.35+0.033*{ ,0.01
PBMC GSH (ng/mg cell protein) 2.460.22 1.960.21* 1.160.13*{ ,0.01
Plasma GSH (mmol/L) 6.860.71 5.160.47* 3.260.38*{ ,0.01
WBC=white blood count; IL-6=interleukin-6; CRP=high-sensitivity C reactive proten; PBMC=peripheral blood mononuclear cells. Data are expressed as means6SD;
*P,0.01 vs non-smokers; {P,0.01 vs moderate smokers.
doi:10.1371/journal.pone.0008225.t002
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Required for oxPAPC-Dependent Expression of Nrf2
Increasing amounts of POVPC, PGPC and PEIPC determined
a dose-dependent, significant rise of ROS in PBMC derived from
healthy volunteers as evaluated by flow cytometry (data not
shown). Figure 7 shows the dose-dependent effect of PGPC (in a
range from 0 to 32 mM) on ROS generation. The PGPC-
dependent generation of ROS was inhibited by the NADPH
inhibitors apocynin and DPI (p,0.01) and by vitamin C (Figure 7).
Furthermore siRNA-mediated knockdown of p47phox deter-
mined a significant reduction of PGPC-dependent expression of
p47phox (Figure 8). The reduction of ROS induced by the
inhibitors of NADPH oxidase and by p47phox siRNA significantly
reduced the expression of Nrf2 (p,0.01) (Figure 9), meaning that
generation of ROS are required for oxPAPC-dependent expres-
sion of Nrf2.
Figure 2. p47phox, IkB-alpha and p65 mRNA and protein expression in peripheral blood mononuclear cells. mRNA (A) was analyzed
by quantitative Real-Time PCR. Normalized gene expression levels were given as the ratio between the mean value for the target gene and that for
the beta-actin in each sample. Figure shows two representative western blot analysis for p47phox, IkB-alpha and p65 (B) and the average
quantification obtained by densitometric analysis of all the samples (C). Data on Western blot analysis are expressed as the density ratio of target to
control (Beta-actin) in arbitrary units610. Results are the means6SD of measurements performed in triplicate. *p,0.01 versus non-smokers; {p,0.01
versus moderate smokers. A=Non-smokers; B=Moderate smokers; C=Heavy smokers; D=Isotype control; E=Positive control.
doi:10.1371/journal.pone.0008225.g002
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Expression
To determine whether Nrf2 is required for PGPC-stimulated
HO-1 and gGCS expression, we used siRNA to knockdown the
expression of Nrf2. Nrf2 siRNA reduced significantly Nrf2 mRNA
expression (data not shown). Figure 10 shows that the knockdown
of Nrf2 was associated to a significant reduction of HO-1 and
gGCS expression induced by PGPC (p,0.01).
Figure 3. Nrf2, HO-1 and gGCS mRNA and protein expression in peripheral blood mononuclear cells. mRNA (A) was analyzed by
quantitative Real-Time PCR. Normalized gene expression levels were given as the ratio between the mean value for the target gene and that for the
beta-actin in each sample. Figure shows two representative western blots analysis for Nrf2, HO-1 and gGCS (B) and the average quantification
obtained by densitometric analysis of all the ssmples (C). Data on Western blot analysis are expressed as the density ratio of target to control (Beta-
actin) in arbitrary units 610. Results are the means6SD of measurements performed in triplicate. *p,0.01 versus non-smokers; {p,0.01 versus
moderate smokers. Nrf2=NF-E2-related factor 2; HO-1=heme oxygenase; gGCS=gamma-glutamylcysteine synthetase; A=Non-smokers;
B=Moderate smokers; C=Heavy smokers; D=Isotype control; E=Positive control.
doi:10.1371/journal.pone.0008225.g003
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of Nrf2 in PBMC Derived from Healthy Donors
Increasing amounts of PGPC (in a range from 0 to 32 mM)
dose-dependently increased NF-kB activation in PBMC derived
from healthy donors (p,0.01) (Figure 11). At these concentrations
the increase of NF-kB activation was associated to a progressive
decrease of Nrf2 expression. Vitamin C dose-dependently
attenuated this phenomenon (Figure 12).
To determine why nuclear NF-kB increase caused a fall in Nrf2
expression we used siRNA to knockdown the expression of NF-
kB/p65. With the highest concentration of PGPC added (32 mM),
p65 siRNA increased about three times the expression of Nrf2
(Figure 13).
Discussion
Overwhelming evidence shows that cigarette smoking is an
important risk factor for atherosclerosis [9]. However the
underlying factors of this deleterious effect are not fully
understood. In this study we showed for the first time that in
healthy young smokers, cigarette smoking is associated with
increased PGPC, POVPC and PEIPC levels in PBMC. Our
results are in line with a series of other studies demonstrating that
cigarette smoking induces systemic oxidative stress (reviewed in
27). The increase of these oxPAPC in PBMC was associated with
the activation of the Nrf2/ARE pathway, that is involved in the
induction of genes coding for a number of antioxidants [15]. The
activation of this pathway, however, was evident only in moderate
smokers, i.e. in subjects smoking no more than 10 cigarettes per
day, while in heavy smokers, i.e. in subjects smoking more than 25
cigarettes per day, the Nrf2/ARE pathway was not activated or
even repressed. The reason for this discrepancy is unclear, but
these results are supported by our in vitro findings showing that at
the highest concentrations of PGPC, the Nrf2/ARE pathway was
no longer stimulated or even reduced. OxPAPC were previously
found to increase ROS production via NADPH-oxidase activation
when added to cultured cells [14]. In in vitro studies we too showed
that PGPC, POVPC and PEIPC singly and dose-dependently rose
the generation of ROS in PBMC derived from healthy donors and
that this increase was related to the activation of NADPH-oxidase.
The oxPAPC-induced increase of ROS was associated to an
induction of Nrf2 expression that was inhibited when the cells
were incubated with NADPH-oxidase inhibitors and with siRNA-
mediated knockdown of p47phox. It is likely that this mechanism
Figure 4. Concentrations of nuclear NF-kB in peripheral blood
mononuclear cells. NF-kB was measured in nuclear extracts of PBMC
utilizing recombinant p65 as a reference. Results are the means6SD of
measurements performed in triplicate. *p,0.01 versus non-smokers;
{p,0.01 versus moderate smokers. NF-kB=nuclear factor-kB.
doi:10.1371/journal.pone.0008225.g004
Figure 5. Interleukin-6 (IL-6) mRNA and protein expression in
peripheral blood mononuclear cells. mRNA (A) was analyzed by
quantitative Real-Time PCR. Normalized gene expression levels were
given as the ratio between the mean value for the target gene and that
for the beta-actin in each sample. Figure shows a representative
western blot analysis for IL-6 and the average quantification obtained
by densitometric analysis of all the samples (B). Data on Western blot
analysis are expressed as the density ratio of target to control (Beta-
actin) in arbitrary units 610. Results are the means6SD of measure-
ments performed in triplicate. *p,0.01 versus non-smokers; {p,0.01
versus moderate smokers.
doi:10.1371/journal.pone.0008225.g005
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reasonably reflects the activity of NADPH-oxidase, was much
higher in the PBMC of heavy smokers who had the highest
concentrations of cellular PGPC, POVPC and PEIPC, than in
moderate smokers or non-smokers. Furthermore the fact that the
concentration of GSH in PBMC was much lower in heavy
smokers than in moderate smokers indicates that oxidative stress
was at the most in the former group. Since it has been suggested
that the Nrf2/ARE pathway is crucial for the regulation of
intracellular redox state [16] and oxidative stress is one of the most
potent stimuli for Nrf2/ARE pathway activation [28], a first
conclusion of this study is that heavy smokers, contrary to
moderate smokers, do not appropriately react in terms of Nrf2/
ARE activation to the intracellular oxidative stress. This
inadequacy of response was also seen in in vitro studies where the
highest degree of oxidative stress did not cause the activation of
Nrf2/ARE pathway. Under different experimental conditions our
results agree with a series of recent studies showing a decline of
Nrf2 expression in whole lung tissue and alveolar macrophages of
patients with pulmonary emphysema [29] and in pulmonary
macrophages of current smokers and patients with chronic
obstructive pulmonary disease [30,31] a pathological situation in
which oxidant-antioxidant imbalance is strongly implicated
[32,33].
The results of this study also demonstrate that contrary to the
Nrf2/ARE pathway, there was a progressive activation of NF-kB
in the PBMC of moderate smokers and heavy smokers compared
to non-smokers and that this activation was associated to a
functional consequence, i.e. the increase of circulating and PBMC
IL-6. A huge amount of experimental data supports the activation
of the transcription factor NF-kB as a key redox-sensitive event
associated with vascular dysfunction (reviewed in 7). So the
progressive increase of NF-kB from non-smokers to heavy smokers
may be related to the oxPAPC-induced generation of ROS. Since
NF-kB intervenes in the transcription of a large number of
inflammatory genes and in particular of IL-6 [8], that induces
CRP in the liver [34], the increase in CRP of smokers may be
related to NF-kB activation. The levels of CRP, even though in the
normal range, were much higher (about three times) in heavy
smokers than in moderate smokers. Of course this may derive
Figure 6. Correlation between the concentration of nuclear NF-
kB and protein expression of Nrf2 in peripheral blood
mononuclear cells of moderate and heavy smokers. NF-kB was
measured in nuclear extracts of PBMC utilizing recombinant p65 as a
reference. Data on protein expression of Nrf2 derived from Western blot
analysis and are expressed as the density ratio of target to control (Beta-
actin) in arbitrary units 610. NF-kB=nuclear factor-kB; Nrf2=NF-E2-
related factor 2.
doi:10.1371/journal.pone.0008225.g006
Figure 7. Effect of NADPH-oxidase inhibitors and vitamin C on
reactive oxygen species (ROS) induced by PGPC in peripheral
blood mononuclear cells. The concentration of PGPC ranged from 0
to 32 mM (A). The inhibitors of NADPH-oxidase apocynin and
diphenyliodonium (DPI) were used at a concentration of 50 mM;
vitamin C at a concentration of 400 mM (B). Data are expressed as
mean fluorescence intensity (MFI) and represent the means6SD of
measurements performed in triplicate in six different occasions.
*p,0.01 versus 0 mM and control; {p,0.01 versus 8 mM; {,0.01 versus
16 mM; #,001 versus PGPC. PGPC=1-palmitoyl-2-glutaroyl-sn-glycero-
3-phosphorylcholine.
doi:10.1371/journal.pone.0008225.g007
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smoked per day and therefore from the greater oxidative stress. In
moderate smokers, but not in heavy smokers however, there may
be the counteracting effect of the Nrf2/ARE apparatus. Nrf2’s
regulation of cellular GSH and other antioxidants has been shown
to be critical for a correct modulation of NF-kB activation [35].
Figure 8. Effect of small interfering (si) and scrambler (sc) RNA
against p47phox on PGPC-dependent expression of p47phox
in peripheral blood mononuclear cells. mRNA (A) was analyzed by
quantitative Real-Time PCR. Normalized gene expression levels were
given as the ratio between the mean value for the target gene and that
for the beta-actin in each sample.. Figure shows a representative
western blot analysis for p47phox and the average quantification
obtained by densitometric analysis of all the samples (B). Data on
Western blot analysis are expressed as the density ratio of target to
control (Beta-actin) in arbitrary units610. Results are the means6SD of
measurements performed in triplicate in six different occasions.
*p,0.01 versus control; {p,0.01 versus PGPC; {,0.01 versus scRNA.
PGPC=1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine.
doi:10.1371/journal.pone.0008225.g008
Figure 9. Effect of small interfering (si) and scrambler (sc) RNA
against Nrf2, apocynin and diphenyliodonium (DPI) on PGPC-
dependent expression of Nrf2 in peripheral blood mononu-
clear cells. PGPC, apocynin and DPI were used at a concentration of 16
and 50 mM respectively. mRNA (A) was analyzed by quantitative Real-
Time. Normalized gene expression levels were given as the ratio
between the mean value for the target gene and that for the beta-actin
in each sample. Figure shows a representative western blot analysis for
Nrf2 and the average quantification obtained by densitometric analysis
of all the samples (B). Data on Western blot analysis are expressed as
the density ratio of target to control (Beta-actin) in arbitrary units 610.
Results are the means6SD of measurements performed in triplicate in
six different occasions. *p,0.01 versus control; {p,0.01 versus PGPC;
{,0.01 versus scRNA. Nrf2=NF-E2-related factor 2; PGPC=1-palmitoyl-
2-glutaroyl-sn-glycero-3-phosphorylcholine.
doi:10.1371/journal.pone.0008225.g009
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regulator of NF-kB activation both by modulating Ik-B degrada-
tion and MyD88-dependent and -independent signalling [35].
The in vitro results on NF-kB are in line with the data we
obtained in vivo. Increasing amounts of PGPC, in fact, dose-
dependently increased the activation of NF-kB in PBMC derived
from healthy donors, while at the highest concentrations Nrf2 was
no longer stimulated. Vitamin C was found to attenuate this
Figure 10. Effect of small interfering (si) and scrambler (sc) RNA
against Nrf2 on PGPC-dependent expression of HO-1 and
gGCS in peripheral blood mononuclear cells. mRNA (A) was
analyzed by quantitative Real-Time PCR. Normalized gene expression
levels were given as the ratio between the mean value for the target
gene and that for the beta-actin in each sample. Figure shows a
representative western blot analysis for HO-1 and gGCS and the
average quantification obtained by densitometric analysis of all the
samples (B). Data on Western blot analysis are expressed as the density
ratio of target to control (Beta-actin) in arbitrary units 610. Results are
the means6SD of measurements performed in triplicate in six different
occasions. *p,0.01 versus control; {p,0.01 versus PGPC; #,0.01
versus PGPC+scRNA. Nrf2=NF-E2-related factor 2; PGPC=1-palmitoyl-
2-glutaroyl-sn-glycero-3-phosphorylcholine; HO-1=heme oxygenase;
gGCS=gamma-glutamylcysteine synthetase.
doi:10.1371/journal.pone.0008225.g010
Figure 11. Effect of PGPC on nuclear NF-kB activation and Nrf2
expression in peripheral blood mononuclear cells. NF-kB (A) was
analyzed as described in materials and methods; Nrf2 mRNA (A) was
analyzed by quantitative Real-Time PCR. Normalized gene expression
levels were given as the ratio between the mean value for the target
gene and that for the beta-actin in each sample. Figure shows a
representative western blot analysis for Nrf2 and the average
quantification obtained by densitometric analysis of all the samples
(B). Data on Western blot analysis are expressed as the density ratio of
target to control (Beta-actin) in arbitrary units 610. Results are the
means6SD of measurements performed in triplicate in six different
occasions. *p,0.01 versus control; {p,0.01 versus 16 mM PGPC;
{ p,0.01versus 24 mM PGPC. NF-kB=nuclear factor-kB; Nrf2=NF-E2-
related factor 2.
doi:10.1371/journal.pone.0008225.g011
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NF-kB activation and in inappropriate Nrf2 expression. Even
though these results have to be confirmed in vivo and therefore do
not allow any conclusion, they are in line with the findings of
Waltenberger et al [36] who found that vitamin C reversed
smoking-induced monocyte dysfunction in vivo.
The reasons for this unexpected result on Nrf2 are unclear.
Recent data have shown that NF-kB p65 subunit repressed the
Nrf2/ARE pathway at transcriptional level [17]. In particular, in
the cells where NF-kB and Nrf2 were simultaneously activated,
p65 unidirectionally antagonized the transcriptional activity of
Nrf2. In our study in order to determine why NF-kB activation
caused a fall in Nrf2 expression, we used siRNA to knockdown the
expression of NF-kB/p65. With the highest concentration of
Figure 12. Effect of increasing amounts of vitamin C on PGPC-
dependent activation of nuclear NF-kB and Nrf2 expression in
peripheral blood mononuclear cells. PGPC was used at a
concentration of 24 mM. NF-kB (A) was analyzed as described in materials
and methods; Nrf2 mRNA (A) was analyzed by quantitative Real-Time
PCR. Normalized gene expression levels were given as the ratio between
the mean value for the target gene and that for the beta-actin in each
sample. Figure shows a representative western blot analysis for Nrf2 and
the average quantification obtained by densitometric analysis of all the
samples (B). Data on Western blot analysis are expressed as the density
ratio oftarget tocontrol (Beta-actin)inarbitrary units610.Results arethe
means6SD of measurements performed in triplicate in six different
occasions. *p,0.01 versus control; {p,0.01 versus 100 mM vitamin C;
{p,0.01 versus 200 mM vitaminC; #p,0.01 versus 300 mM vitamin C.
PGPC=1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine; NF-
kB=nuclear factor-kB, Nrf2=Nrf2=NF-E2-related factor 2.
doi:10.1371/journal.pone.0008225.g012
Figure 13. Effect of small interfering (si) and scrambler (sc) RNA
against p65 on PGPC-dependent expression of Nrf2 in
peripheral blood mononuclear cells. PGPC was used at a
concentration of 32 mM. mRNA (A) was analyzed by quantitative Real-
Time PCR. Normalized gene expression levels were given as the ratio
between the mean value for the target gene and that for the beta-actin
in each sample. Figure shows a representative western blot for Nrf2 and
the average quantification obtained by densitometric analysis of all the
samples (B). Data on Western blot analysis are expressed as the density
ratio of target to control (Beta-actin) in arbitrary units 610. Results are
the means6SD of measurements performed in triplicate in six different
occasions. *p,0.01 versus control; {p,0.01 versus scRNA. PGPC=1-
palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine; Nrf2=NF-E2-re-
lated factor 2.
doi:10.1371/journal.pone.0008225.g013
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expression of Nrf2 suggesting that the Nrf2 repression may be
related to the p65 antagonism. Of course on the basis of these
results we cannot exclude that Nrf2 decline in heavy smokers may
also be related to other mechanisms and in particular to decreased
Nrf2 protein stability as recently demonstrated in patients with
COPD [31].
In conclusion the results of this study show that cigarette
smoking is associated with increased oxPAPC in PBMC of young
healthy smokers with no additional risk factors for atherosclerosis.
This means that water-soluble components of cigarette smoke
reach the systemic circulation and can promote oxidative stress not
only of blood cells but probably also of vasculature cells. Increased
oxPAPC and in particular PGPC, POVPC and PEIPC were
associated with the activation of the Nrf2/ARE pathway only in
moderate smokers and not in heavy smokers, while NF-kB was
progressively more activated from non-smokers to heavy smokers.
This investigation revealed that NF-kB p65 may participate in the
negative regulation of Nrf2/ARE signalling, and might provide a
new insight into a possible role of NF-kB in suppressing the
expression of antioxidant genes, favouring inflammation.
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